Literature DB >> 8182150

Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

C Ferran1, F Dautry, S Mérite, K Sheehan, R Schreiber, G Grau, J F Bach, L Chatenoud.   

Abstract

De novo expression of TNF, IFN gamma, IL-3, IL-4, and IL-6 genes was initiated rapidly by treatment of mice with anti-CD3. A specific feature of this reaction was that TNF was derived exclusively from T cells. TNF was produced both as a mature soluble trimeric protein and as a 26-kD anti-TNF-reactive protein compatible with membrane-anchored TNF. Pretreatment with anti-TNF did not affect anti-CD3-triggered TNF mRNA expression in T cells. In contrast, in vivo and in vitro anti-TNF treatment upregulated anti-CD3-induced IFN gamma mRNA expression and inhibited IL-4 mRNA expression. These latter effects were not dependent on TNF neutralization: pretreatment with soluble recombinant 55-kD TNF receptor (TBPI) as an alternative TNF-neutralizing agent did not modify the anti-CD3-induced cytokine profile. These results suggest that a direct interaction between anti-TNF and T cell membrane-anchored TNF could account for the observed modulation of cytokine gene expression. The increased expression of INF gamma mRNA observed in anti-TNF-treated animals correlated with a decrease in IL-3 and IL-6 mRNA expression. Conversely, IFN gamma blockade by a neutralizing anti-IFN gamma mAb led to a substantial increase in both IL-3 and IL-6 gene expression induced by anti-CD3. Taken together, these results strongly argue for the existence, in the anti-CD3-induced cytokine cascade, of IFN gamma-dependent regulation of IL-3 production, which in turn modulates IL-6 production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182150      PMCID: PMC294360          DOI: 10.1172/JCI117215

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

2.  cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

Authors:  J Van Snick; S Cayphas; J P Szikora; J C Renauld; E Van Roost; T Boon; R J Simpson
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

3.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

Authors:  M Kriegler; C Perez; K DeFay; I Albert; S D Lu
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.

Authors:  G E Grau; V Kindler; P F Piguet; P H Lambert; P Vassalli
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

6.  Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.

Authors:  L Fransen; R Müller; A Marmenout; J Tavernier; J Van der Heyden; E Kawashima; A Chollet; R Tizard; H Van Heuverswyn; A Van Vliet
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

Review 7.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

8.  Interleukin 2 and concanavalin A stimulate interferon-gamma production in a murine cytolytic T cell clone by different pathways.

Authors:  D E Dunn; K C Herold; G R Otten; D W Lancki; T Gajewski; S N Vogel; F W Fitch
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

9.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

Authors:  M C Cuturi; M Murphy; M P Costa-Giomi; R Weinmann; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  19 in total

1.  Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Authors:  R T Meijer; S L Yong; I J ten Berge; R A van Lier; P T Schellekens
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Acute inflammation alters bicarbonate transport in mouse ileum.

Authors:  Hui Zhang; Nadia Ameen; James E Melvin; Sadasivan Vidyasagar
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

3.  Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells.

Authors:  Hailong Zhang; Dan Yan; Xu Shi; Huifang Liang; Yan Pang; Nalin Qin; Hui Chen; Jing Wang; Bingjiao Yin; Xiaodan Jiang; Wei Feng; Wenjie Zhang; Muxiang Zhou; Zhuoya Li
Journal:  J Leukoc Biol       Date:  2008-06-11       Impact factor: 4.962

4.  Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome.

Authors:  Sylvain Perruche; Pin Zhang; Takashi Maruyama; Jeffrey A Bluestone; Philippe Saas; WanJun Chen
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Detection of TNF alpha and Fas ligand mRNA within synovial mononuclear cells by fluorescence in-cell labeling PCR (FICL-PCR).

Authors:  M Okubo; M P Brown; K Chiba; R Kasukawa; T Nishimaki
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

Review 6.  Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

Authors:  Lucienne Chatenoud
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 7.  Challenges in the pursuit of immune tolerance.

Authors:  Gerald T Nepom; E William St Clair; Laurence A Turka
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

8.  Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.

Authors:  Nalini K Vudattu; Ernst Holler; Patricia Ewing; Ute Schulz; Silvia Haffner; Verena Burger; Silvia Kirchner; Reinhard Andreesen; Günther Eissner
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

9.  Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.

Authors:  R T Meijer; S Surachno; S L Yong; F J Bemelman; S Florquin; I J M Ten Berge; P T A Schellekens
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection.

Authors:  B M Saunders; H Briscoe; W J Britton
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.